Clinical Trial Update: Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687 [Phase 1]

View source ↗

Summary

This is a Phase 1 Japanese single and multiple ascending dose study of AZD7687 assessing safety, tolerability, pharmacokinetics and pharmacodynamics, completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD7687

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes, Obesity | Phase 1 | Status: COMPLETED